Merkel Cell Carcinoma: An Unusually Immunogenic Cancer Proves Ripe for Immune Therapy.

Vandeven N, Nghiem P.

J Oncol Pract. 2016 Jul;12(7):649-50.

PMID: 27407162

View on PubMed - View PDF

J Oncol Pract. 2016 Jul;12(7):649-50.

previous post: PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
next post: Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.